RAC 2.20% $1.78 race oncology ltd

Ann: A$3m strategic investment from prominent biotech investors, page-17

  1. 1,379 Posts.
    lightbulb Created with Sketch. 209
    Not very pleased with the price but very interesting that Dave Williams has come on board, known for his competent deal making and last year come on board for Bard1 when they done a CR at 2c, which at the time I wasn’t to pleased about, immediately jumped on reopening and a week later doubled in price.
    Lets see what happens here, still got full faith in management
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.